Finance

Lists
NRC:NASDAQ
NRC Health
$24.26
+1.80%
(+0.43) 1D
$24.26
0.00% (0.00)
After hours
Closed: Nov 2, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NRC...
Open
$24.02
High
$24.69
Low
$23.84
Mkt. cap
514.83M
Avg. vol.
103.00K
Volume
15.00
Dividend
2.64%
Quarterly dividend
$0.16
Ex-dividend date
Sep 25, 2026
P/E ratio
86.30
52-wk high
$24.69
52-wk low
$11.74
EPS
$0.28
Beta
0.25
Shares outstanding
22.12M
No. of employees
357
Open
$24.02
High
$24.69
Low
$23.84
Mkt. cap
514.83M
Avg. vol.
103.00K
Volume
15.00
Dividend
2.64%
Quarterly dividend
$0.16
Ex-dividend date
Sep 25, 2026
P/E ratio
86.30
52-wk high
$24.69
52-wk low
$11.74
EPS
$0.28
Beta
0.25
Shares outstanding
22.12M
No. of employees
357
News stories
From web sources and news partners
Profile
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska. The company changed its corporate name from National Research Corporation to NRC Health, Inc. in April 2026. Wikipedia
About NRC Health
CEOMichael Hays
Employees357
Founded1981
HeadquartersLincoln, Nebraska, United States
SectorHealth care provider
Analyst ratings
Based on 1 analyst giving stock ratings to NRC in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for NRC in the last 3 months
Highest
Current $24.26
$27.00 (+11.29%)
Average
$27.00 (+11.29%)
Lowest
$27.00 (+11.29%)
Analyst
Recommendation
Action
Price target
Projected
Date
Constantine Davides
Citizens JMP
Buy
Maintained
$27.00
+11.3%
10/28/2026
Last report
Oct 27, 2026
Fiscal period
Q3 2026
$0.21 / $0.18
+16.67%beat
Revenue / Est. (USD)
38.40M / 35.80M
+7.26%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
35.19M
34.80M
35.39M
38.40M
Cost of goods sold
13.94M
13.65M
13.56M
15.38M
Cost of revenue
13.94M
13.65M
13.56M
15.38M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.79M
13.42M
19.78M
12.04M
Operating expense
9.94M
15.59M
21.91M
14.11M
Total operating expenses
23.87M
29.23M
35.47M
29.49M
Operating income
11.32M
5.57M
-78.00K
8.91M
Other non operating income
-61.00K
30.00K
2.00K
-
EBT including unusual items
3.27M
4.38M
-4.54M
7.40M
EBT excluding unusual items
9.92M
4.38M
-1.38M
7.40M
Income tax expense
1.47M
1.16M
-1.25M
2.70M
Effective tax rate
45.00%
26.42%
27.64%
36.45%
Other operating expenses
-
-
-
-
Net income
1.80M
3.22M
-3.28M
4.70M
Net profit margin
5.11%
9.26%
-9.28%
12.25%
Earnings per share
-
-
0.31
0.21
Interest and investment income
29.00K
35.00K
20.00K
26.00K
Interest expense
-1.37M
-1.26M
-1.32M
-1.53M
Net interest expenses
-1.34M
-1.22M
-1.30M
-1.51M
Depreciation and amortization charges
2.14M
2.17M
2.12M
2.07M
EBITDA
13.47M
7.74M
2.04M
10.98M
Gain or loss from assets sale
61.00K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps